Drug · DIN 02537532
ZORYVE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 29, 2025; first marketed June 2, 2023.
- Drug Identification Number (DIN)
- 02537532
- Company (DIN owner)
- Arcutis Canada, Inc.North York, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Roflumilast D05AX06
- Class
- Human
- Record last updated
- August 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROFLUMILAST | 0.3 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 7, 2023: NOC 32044New Drug Submission (NDS) · Administrative: Change in Product Ownership
- April 28, 2023: NOC 30608New Drug Submission (NDS)
Other DINs named ZORYVE
- DIN 02552566 · Marketed
- DIN 02556146 · Marketed
- DIN 02570793 · Marketed